{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:56:54Z","timestamp":1758121014380},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,10,23]],"date-time":"2010-10-23T00:00:00Z","timestamp":1287792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s10067-010-1605-1","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T05:16:50Z","timestamp":1287724610000},"page":"399-401","source":"Crossref","is-referenced-by-count":15,"title":["Tuberculosis and anti-TNF treatment: experience of a central London hospital"],"prefix":"10.1007","volume":"30","author":[{"given":"Satveer","family":"Mankia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Ehrenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,23]]},"reference":[{"key":"1605_CR1","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1002\/art.23364","volume":"58","author":"YP Goekoop-Ruiterman","year":"2008","unstructured":"Goekoop-Ruiterman YP, de Vries-Bowstra JK, Allaart CF et al (2008) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomised controlled trial. Arthritis Rheum 58:S126\u2013S135","journal-title":"Arthritis Rheum"},{"key":"1605_CR2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","volume":"60","author":"LP Omerod","year":"2005","unstructured":"Omerod LP, Milburn HJ, Gillespie S, Ledingham J, Rampton D (2005) BTS recommendations for assessing risk, and for managing M. tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 60:800\u2013805","journal-title":"Thorax"},{"key":"1605_CR3","unstructured":"Anderson C, Moore J, Kruijshaar M, Abubakar I. (2008) Tuberculosis in the UK. Annual Report on Tuberculosis Surveillance in the UK 2008. London: Health Protection Agency Centre for Infections."},{"key":"1605_CR4","unstructured":"Global tuberculosis control: epidemiology, financing, strategy: WHO report 2009."},{"key":"1605_CR5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","volume":"69","author":"WG Dixon","year":"2010","unstructured":"Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A (2010) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 69:522\u2013528","journal-title":"Ann Rheum Dis"},{"key":"1605_CR6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/ard.2006.066761","volume":"66","author":"GR Burmester","year":"2007","unstructured":"Burmester GR, Mariette X, Montecucco C et al (2007) Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the research in active rheumatoid arthritis (ReAct) trial. Ann Rheum Dis 66:732\u2013739","journal-title":"Ann Rheum Dis"},{"key":"1605_CR7","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","volume":"60","author":"F Tubach","year":"2009","unstructured":"Tubach F, Salmon D, Ravaud P et al (2009) Risk of tuberculosis is higher with anti-tumour necrosis factor monoclonal antibody therapy than with soluble tumour necrosis factor therapy: the three-year prospective French research axed on tolerance of biotherapies registry. Arthritis Rheum 60:1884\u20131894","journal-title":"Arthritis Rheum"},{"key":"1605_CR8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","volume":"59","author":"KG Saag","year":"2008","unstructured":"Saag KG, Teng GG, Patkar NM et al (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59:762\u2013784","journal-title":"Arthritis Rheum"},{"key":"1605_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2807\/esm.11.03.00604-en","volume":"11","author":"O Infuso","year":"2006","unstructured":"Infuso O, Falzon D (2006) European survey of BCG vaccination policies and surveillance in children, 2005. Euro Surveill 11:6\u201311","journal-title":"Euro Surveill"},{"key":"1605_CR10","first-page":"834","volume":"14","author":"I Sauzullo","year":"2010","unstructured":"Sauzullo I, Mengoni F, Scrivo R et al (2010) Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patients candidate for anti-tumour necrosis-alpha treatment. Int J Tuberc Lung Dis 14:834\u2013840","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1605-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1605-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T19:08:16Z","timestamp":1559761696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1605-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,23]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1605"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1605-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,23]]}}}